MIRA
INFORM REPORT
|
Report Date : |
12.02.2008 |
IDENTIFICATION
DETAILS
|
Name : |
FRANCK PHARMA |
|
|
|
|
Registered Office : |
Lot VV 197E Bis manakambahiny Tannanaive 101 |
|
|
|
|
Country : |
Madagascar |
|
|
|
|
Date of Incorporation : |
16.7.2000 |
|
|
|
|
Legal Form : |
Limited Liability Company, Limited by Shares |
|
|
|
|
Line of Business : |
Importer and Distributor of the Medicines, Health Care and Related
Products |
RATING &
COMMENTS
|
MIRA’s Rating : |
B |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
26-40 |
B |
Unfavourable & favourable factors carry similar weight in credit
consideration. Capability to overcome financial difficulties seems
comparatively below average. |
Small |
|
Maximum Credit Limit : |
USD 50,000 |
|
|
|
|
Status : |
Small Company |
|
|
|
|
Payment Behaviour : |
No Complaints |
|
|
|
|
Litigation : |
Clear |
COMPANY REPORTED
FRANCK PHARMA
Other Name
FRANCK INTERNATIONAL
Principal Address
Lot VV 197E Bis manakambahiny Tannanaive 101 Madagascar
Telephone: +261-2-313706
Fax: +261-2-313706
Email: info@franckinternational.com
Internet: www.franckinternational.com
Established
16/7/2000
Registration
Madagascar
Legal Form
Limited Liability
Company, Limited by shares
Stock Listing
Not Listed
Workforce
2007
30
Office & Factories
Head offices Lot VV 197E Bis manakambahiny Tannanaive 101
Madagascar
Branches None
Company Profile
Paid in Capital MGF. 10,000,000
Subscribed Capital MGF. 10,000,000
Shareholders
Name Position Amount
Ratio
Mr. Srinivas Kumar CEO 50.00%
Mr. Arun
Kumar Director 50.00%
Total 100.00%
Credit Opinion
Our proposed credit amount of USD 50,000 is recommendable
Companies Divisions
Division (1) FRANCK
EXPORTS
Company (2) FRANCK SERVICES
Management/ Directors
President/ CEO (1)
Name Mr. Srinivas Kumar
Remarks Top
Decision Maker
President/ CEO (2)
Name Mr.
Arun Kumar
Þ Top decision maker is the person who has the
ultimate authority or power to make important managerial decisions. He/She may
or may not be officially registered as a president or an executive director.
Business Activities
Importer and
distributor of the medicines, health care and related products etc
Terms of payment
Buying terms 30% in cash, 70% on credit
Selling terms 80% in cash, 20% on credit
Suppliers
None
Customers
Local agencies, stores and
outlets
Recent Sales
MGF. 245,000,000 (2007)
Exports
None
Export Ratio
0.0%
Import Ratio
60.0%
Domestic Market Share
20.0%
Banking relationship
Main Banks BFV-Societe Generale
Credit Check of Subject,
President & CEO (as of report date)
Payment Morale: In the documents at our disposal nothing adverse has been shown
so far.
CREDIT RATING: Financial situation is
average.
COMMENTS
Maximum credit we recommend is USD 50,000 outstanding at any one time.
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit transaction.
It has above average (strong) capability for payment of interest and
principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General unfavourable
factors will not cause fatal effect. Satisfactory capability for payment of
interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Unfavourable & favourable factors carry similar weight in credit
consideration. Capability to overcome financial difficulties seems
comparatively below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
NR |
In view of the lack of information, we have no basis upon which to
recommend credit dealings |
No Rating |
|
This score serves as a reference to
assess SC’s credit risk and to set the amount of credit to be extended. It is
calculated from a composite of weighted scores obtained from each of the major
sections of this report. The assessed factors and their relative weights (as
indicated through %) are as follows:
Financial condition (40%) Ownership background (20%) Payment
record (10%)
Credit history (10%) Market trend (10%) Operational
size (10%)